EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

EGFR Inhibition by Erlotinib Rescues Desmosome Ultrastructure and Keratin Anchorage and Protects against Pemphigus Vulgaris IgG–Induced Acantholysis in Human Epidermis

Desalegn Tadesse Egu, Thomas Schmitt, Nancy Ernst, Ralf Joachim Ludwig, Michael Fuchs, Matthias Hiermaier, Sina Moztarzadeh, Carla Sebastià Morón, Enno Schmidt, Vivien Beyersdorfer, Volker Spindler, Letyfee Sarah Steinert und 3 weitere

Journal of Investigative Dermatology · 2024

DOI: 10.1016/j.jid.2024.03.040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2024. Verfasst von Desalegn Tadesse Egu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Anatomy, Faculty of Medicine, Ludwig Maximilian University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Pemphigus, Erlotinib Hydrochloride, ErbB Receptors, Desmosomes. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, LMU Munich.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pemphigus is a severe blistering disease caused by autoantibodies primarily against the desmosomal cadherins desmoglein (DSG)1 and DSG3, which impair desmosome integrity. Especially for the acute phase, additional treatment options allowing to reduce corticosteroids would fulfill an unmet medical need. In this study, we provide evidence that EGFR inhibition by erlotinib ameliorates pemphigus vulgaris IgG-induced acantholysis in intact human epidermis. Pemphigus vulgaris IgG caused phosphorylation of EGFR (Y845) and Rous sarcoma-related kinase in human epidermis. In line with this, a phosphotyrosine kinome analysis revealed a robust response associated with EGFR and Rous sarcoma-related kinase family kinase signaling in response to pemphigus vulgaris IgG but not to pemphigus foliaceus autoantibodies. Erlotinib inhibited pemphigus vulgaris IgG-induced epidermal blistering and EGFR phosphorylation, loss of desmosomes, as well as ultrastructural alterations of desmosome size, plaque symmetry, and keratin filament insertion and restored the desmosome midline considered as hallmark of mature desmosomes. Erlotinib enhanced both single-molecule DSG3-binding frequency and strength and delayed DSG3 fluorescence recovery, supporting that EGFR inhibition increases DSG3 availability and cytoskeletal anchorage. Our data indicate that EGFR is a promising target for pemphigus therapy owing to its link to several signaling pathways known to be involved in pemphigus pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PemphigusErlotinib HydrochlorideErbB ReceptorsDesmosomesEpidermisAcantholysisImmunoglobulin GKeratinsHumansPhosphorylationDesmoglein 3Protein Kinase InhibitorsSignal Transduction

Stichwörter der Autor:innen

DesmogleinsEGFR signalingErlotinibPemphigus

Substanzen

Erlotinib HydrochlorideErbB ReceptorsEGFR protein, humanImmunoglobulin GKeratinsDesmoglein 3Protein Kinase InhibitorsDSG3 protein, human

Autor:innen und Institutionen

  • Institute of Anatomy, Faculty of Medicine, Ludwig Maximilian University of Munich, Munich, Germany.
  • Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany; Department of Dermatology, University of Lübeck, Lübeck, Germany.
  • Institute of Anatomy, Faculty of Medicine, Ludwig Maximilian University of Munich, Munich, Germany; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
  • Department of Biomedicine, University of Basel, Basel, Switzerland; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Institute of Anatomy, Faculty of Medicine, Ludwig Maximilian University of Munich, Munich, Germany. Electronic address: Jens.Waschke@med.uni-muenchen.de.

Förderung

  • Deutsche Forschungsgemeinschaft
  • LMU Munich

Zitieren

APA

Egu, D. T., Schmitt, T., Ernst, N., Ludwig, R. J., Fuchs, M., Hiermaier, M., Moztarzadeh, S., Morón, C. S., Schmidt, E., Beyersdorfer, V., Spindler, V., Steinert, L. S., Vielmuth, F., Sigmund, A. M., & Waschke, J. (2024). EGFR Inhibition by Erlotinib Rescues Desmosome Ultrastructure and Keratin Anchorage and Protects against Pemphigus Vulgaris IgG–Induced Acantholysis in Human Epidermis. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2024.03.040

Vancouver

Egu DT, Schmitt T, Ernst N, Ludwig RJ, Fuchs M, Hiermaier M, et al. EGFR Inhibition by Erlotinib Rescues Desmosome Ultrastructure and Keratin Anchorage and Protects against Pemphigus Vulgaris IgG–Induced Acantholysis in Human Epidermis. Journal of Investigative Dermatology. 2024. doi:10.1016/j.jid.2024.03.040

BibTeX
@article{Egu2024,
  author = {Egu, Desalegn Tadesse and Schmitt, Thomas and Ernst, Nancy and Ludwig, Ralf Joachim and Fuchs, Michael and Hiermaier, Matthias and Moztarzadeh, Sina and Morón, Carla Sebastià and Schmidt, Enno and Beyersdorfer, Vivien and Spindler, Volker and Steinert, Letyfee Sarah and Vielmuth, Franziska and Sigmund, Anna Magdalena and Waschke, Jens},
  title = {EGFR Inhibition by Erlotinib Rescues Desmosome Ultrastructure and Keratin Anchorage and Protects against Pemphigus Vulgaris IgG–Induced Acantholysis in Human Epidermis},
  journal = {Journal of Investigative Dermatology},
  year = {2024},
  doi = {10.1016/j.jid.2024.03.040}
}
Kostenlos starten →